Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information


EU orphan designation number: EU/3/14/1324   
Active ingredient: 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethylsulfamide
Indication: Treatment of small cell lung cancer
Sponsor: DualTpharma B.V.
Bosschstraat 111 D 01, 6211 AW Maastricht, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/08/2014 Orphan designation EMA/OD/086/14 (2014)6129 of 22/08/2014